U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285148) titled 'A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer' on Nov. 04.
Brief Summary: Protocol Title
A Study to Evaluate ANS014004 in Combination with EGFR-TKI in Patients with EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
The main purpose of this research study is to
Find a safe and tolerable dose of two investigational drugs, ANS014004 and PLB1004, when used together.
Learn how effective this drug combination is at treating a type of lung cancer called "EGFR mutation-positive non-small cell lung cancer (NSCLC)" that has spread to other parts of the body (locally...